Growth/Buyout Portfolio - Seqens


Key figures

  • 2002
    Creation Date
  • 2956
    Number of Employees
  • 2016
    Investment Date
  • Mérieux Participations 2
    Fund Name

Company presentation

Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to their customers.

With 24 manufacturing sites and 3 R&D centers in Europe, North America and Asia, Seqens develops custom solutions and ingredients for the most demanding industries such as healthcare, electronics, cosmetics, food and homecare.

Seqens is the new name for Novacap and all its activities as of December 2018.


21 Chemin de la Sauvegarde - 69130 Ecully - FRANCE

Key contacts